Ruypeptide Biotechnology Co., Ltd.** is expanding its international presence by strengthening its biotechnology research capabilities, manufacturing capacity, and global customer support as demand for ...

Germany-headquartered science and technology giant Merck will continue to deepen its presence in China's healthcare sector, ...

Jubilant Biosys, an integrated drug discovery and development partner, convened the 2nd EDGE Innovation Forum in San Diego on ...

Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese ...

Biopharmaceutical innovation has traditionally been difficult to capture through market exposures. This article explores how ...

New initiative under NSG Bio Tomorrow will support promising startups developing next-generation approaches in respiratory and neonatal care ...

Once attention exists, you have the opportunity to explain the mission, communicate the science clearly, build trust and ...

CPIC 2026 opens in Shanghai on July 22. [Photo provided to chinadaily.com.cn] Global pharmaceutical leaders convened in ...

India's NITI Aayog has unveiled a blueprint for a $691 billion bioeconomy by 2035, proposing a ₹50,000-crore growth fund, six ...

Priyanka Aggarwal, India and South East Asia Leader, Healthcare Practice at Boston Consulting Group (BCG), said patent ...

This article is authored by Dhananjay Singh, managing director, Merck Life Science & head, Discovery Solutions, India.

The United States and China are engaged in a competition that will shape far more than the future of medicine.